Collagen Patents (Class 128/DIG8)
  • Patent number: 4389487
    Abstract: Process for the preparation of collagen products for medical and cosmetic purposes, wherein collagen products prepared according to the method described in U.S. Pat. No. 4,066,083 are subjected to an additional heat treatment or a treatment with gaseous hydrogen halide in order to improve the physicochemical and mechanical properties of the collagen product, in particular its absorption and mechanical strength.
    Type: Grant
    Filed: June 8, 1981
    Date of Patent: June 21, 1983
    Assignee: Pentapharm A.G.
    Inventor: Peter E. Ries
  • Patent number: 4378017
    Abstract: A composite material of de-N-acetylated chitin and fibrous collagen, which may be prepared by bringing the de-N-acetylated chitin and the fibrous collagen into mutual contact in an aqueous acidic medium followed by deacidifying the obtained product, the fibrous collagen being able to be partially replaced by gelatin and/or soluble collagen, and a shaped material derived from the composite material is excellent in mechanical strength, heat-resistance and biostability and advantageously employed in the field of medical materials, edibles such as edible casing and base materials for inmobilizing enzyme.
    Type: Grant
    Filed: March 11, 1981
    Date of Patent: March 29, 1983
    Assignee: Kureha Kagaku Kogyo Kabushiki Kaisha
    Inventors: Junichi Kosugi, Tadaaki Kato, Masayuki Funabashi
  • Patent number: 4357274
    Abstract: In a process for the manufacture of sclero protein transplants in which raw sclero protein from humans or animals is watered, treated with H.sub.2 O.sub.2, degreased, rinsed, dried and sterilized, the improvement in which the sclero protein, after rinsing and prior to drying, is treated with glycerin or polyethylene glycol.
    Type: Grant
    Filed: August 6, 1981
    Date of Patent: November 2, 1982
    Assignee: Intermedicat GmbH
    Inventor: Heinz-Helmut Werner
  • Patent number: 4356236
    Abstract: A spherically shaped material at least the surface layer of which comprises an acylated product of de-N-acetylated chitin. The spherical material is insoluble in water, acids, alkaline solutions and organic solvents. The materials can be employed to separate materials on a column, as a base material on which enzyme is immobilized and as an adsorbent, etc.
    Type: Grant
    Filed: June 4, 1980
    Date of Patent: October 26, 1982
    Assignee: Kureha Kagaku Kogyo Kabushiki Kaisha
    Inventor: Junichi Koshugi
  • Patent number: 4350629
    Abstract: This invention relates to crosslinked collagen and glycosaminoglycan materials, and to procedures for preparing such materials. It has been discovered that if collagen fibrils in an aqueous acidic solution are contacted with a crosslinking agent before being contacted with glycosaminoglycan, the materials produced have extremely low levels of thrombogenicity. Such materials are well suited for in-dwelling catheters, blood vessel grafts, and other devices that are in continuous contact with blood for long periods of time.
    Type: Grant
    Filed: July 29, 1981
    Date of Patent: September 21, 1982
    Assignee: Massachusetts Institute of Technology
    Inventors: Ioannis V. Yannas, Martin J. Forbes
  • Patent number: 4349026
    Abstract: A novel collagen condom consists of isotropically-strong, crosslinked, regenerated fiber collagen. A method of preparation involves the steps of at least twice dipping a mandrel into an acidic collagen dispersion; slowly removing the mandrel under spinning conditions; neutralizing and drying the membrane between dippings; crosslinking the finally dried membrane while on the mandrel and removing the membrane from the mandrel.
    Type: Grant
    Filed: February 28, 1980
    Date of Patent: September 14, 1982
    Assignee: Collagen Development Corp.
    Inventor: Teruo Miyata
  • Patent number: 4300243
    Abstract: Biological collagenous material is preserved by dehydrating utilizing an organic water-miscible solvent.
    Type: Grant
    Filed: February 8, 1980
    Date of Patent: November 17, 1981
    Assignee: Pfrimmer & Co., Pharmazeutische Werke Erlangen GmbH
    Inventor: Ludwig Baumgartner
  • Patent number: 4298004
    Abstract: A method for altering the radius of curvature of the cornea together with an apparatus for use therein is provided. Apparatus (10) includes a circular ring (12) which can be placed over the eye for concentrically surrounding the cornea. Blade (14) which forms a part of apparatus (10) is mounted for retractable movement to and away from the cornea. Blade (14) is also able to rotate through a limited arc so that a sector-shaped incision (46) can be made in the cornea. Collagen or any other suitable material (50) is injected into sector-shaped incision (46) to alter the radius of curvature of the cornea.
    Type: Grant
    Filed: February 27, 1979
    Date of Patent: November 3, 1981
    Inventors: Ronald A. Schachar, Norman S. Levy
  • Patent number: 4294241
    Abstract: Skin or wound dressings are prepared in gel or sheet form from enzyme-solubilized collagen and/or such chemically modified collagen. Improved sheet form dressing is prepared by tubular extrusion of such collagen gels.
    Type: Grant
    Filed: October 19, 1979
    Date of Patent: October 13, 1981
    Inventor: Teruo Miyata
  • Patent number: 4279812
    Abstract: Macromolecular reconstituted collagen is prepared by treating natural insoluble collagen with an aqueous solution comprised of an alkali sulfate salt and an alkali metal hydroxide for at least 48 hours to saponify fats suspended within the natural insoluble collagen. The fat free collagen is then treated with an aqueous solution comprised of an alkali metal sulfate for at least four hours to stabilize the interfibular bonds between individual polypeptide chains. The collagen is then dissolved in an aqueous acid solution and frozen at a rate of -20.degree. C./hour. The frozen collagen is vacuum dried at 10.sup.-3 to 10.sup.-5 torr for at least 16 hours to produce a biologically active collagen article. Various biologically active materials may be added to the aqueous acid solution prior to freezing. The collagen product may then be implanted into an animal or the like and the medication slowly released.
    Type: Grant
    Filed: September 12, 1979
    Date of Patent: July 21, 1981
    Assignee: Seton Company
    Inventor: Gheorghe Cioca
  • Patent number: 4274410
    Abstract: A contraceptive device and method of contraception as well as a method of making the contraceptive device are described. Native collagen form of fibrillar protein is comminuted and homogenized in an acid environment; noncollagenous material is removed and residual collagen is mixed with water the pH of the resulting slurry is adjusted to 4.5 to 5.0 by the addition of acetic acid; gluteraldehyde is then added and the slurry poured into molds and frozen at approximately -10.degree. centigrade for approximately 20 hours. The frozen mass is then thawed, washed, and immersed in a wash of pH 8 to 9 for approximately 2 hours at 20.degree. centigrade. Sufficient reducing agent is added to the wash to create excess reducing equivalents. The sponge is then immersed in a buffer solution of pH 4 to 5 for a time sufficient to equilibrate to uniform pH. The sponge formed by the above method is then moistened and self-administered in the upper vault of the vagina proximal to the cervix.
    Type: Grant
    Filed: January 16, 1980
    Date of Patent: June 23, 1981
    Assignee: Medi-Coll, Inc.
    Inventor: Milos Chvapil
  • Patent number: 4271070
    Abstract: Chemically-modified quaternary-structured fiber collagens of minimum molecular length, diameter and periodicity, and containing a relatively high positive electrostatic charge are claimed as hemostatic agents. Specific examples are guanidinated, esterified, and guanidinated-esterified collagen fibers of the type described.
    Type: Grant
    Filed: May 5, 1980
    Date of Patent: June 2, 1981
    Assignee: Cornell Research Foundation, Inc.
    Inventors: Teruo Miyata, Albert L. Rubin, Kurt H. Stenzel
  • Patent number: 4238480
    Abstract: An improved hemostatic agent is made by treating collagen or collagen-like substance to render the surface charge thereof effectively more positive. The thusly modified substance is employed to control or terminate bleeding.
    Type: Grant
    Filed: May 19, 1978
    Date of Patent: December 9, 1980
    Inventor: Philip N. Sawyer
  • Patent number: 4233360
    Abstract: Collagen, available from domestic animals, is freed of noncollagen proteins, glycosaminoglycans and lipids by enzymatic treatment with a proteolytic enzyme to yield a product which is soluble in dilute acidic aqueous solutions (collagen in solution--CIS). The naturally occurring collagen is modified by removal of certain terminal peptide chains, which are described as telopeptides. The modified collagen, so derived, is described as atelopeptide collagen. Native collagen is immunogenic, while atelopeptide collagen is nonimmunogenic or possessed of a negligibly low level of immunogenicity.The collagen in solution is then treated according to a specific regimen under conditions whereby the collagen slowly separates from solution while exposed to mild shear forces. This procedure results in the formation of a fibrous precipitate composed of regularly ordered fibers of collagen possessed of a ropelike structure. These resulting aggregates are referred to as native fibrous micropolymers (NFM).
    Type: Grant
    Filed: September 25, 1978
    Date of Patent: November 11, 1980
    Assignee: Collagen Corporation
    Inventors: Edward E. Luck, John R. Daniels
  • Patent number: 4223984
    Abstract: Soft contact lenses are made from solubilized, defatted, transparent, cross-linked collagen, and/or chemically-modified collagen.
    Type: Grant
    Filed: April 4, 1979
    Date of Patent: September 23, 1980
    Assignee: Opticol Corporation
    Inventors: Teruo Miyata, Albert L. Rubin, Michael W. Dunn, Kurt H. Stenzel
  • Patent number: 4215200
    Abstract: Polymers of quaternary-structured collagen of minimum length, diameter and periodicity, and containing a relatively high positive electrostatic charge are claimed as hemostatic agents. Specific examples are guanidnated polymers of the type described, esterified polymers, and esterified-guanidinated polymers.
    Type: Grant
    Filed: October 2, 1978
    Date of Patent: July 29, 1980
    Assignee: Cornell Research Foundation, Inc.
    Inventors: Teruo Miyata, Kurt H. Stenzel, Albert L. Rubin
  • Patent number: 4131650
    Abstract: In the treatment of skin wherein an aqueous paste is applied to the skin, left in contact therewith for a period of time and thereafter removed, the improvement which comprises placing over the paste a foil containing at least about 3 percent of water soluble collagen by weight and having a water permeability of more than about 0.1 gram/dm.sup.2 /minute, whereby collagen is transported through the paste and is absorbed by the skin. Desirably the foil is about 0.01 to 0.03 mm thick and is cross-linked to an extent corresponding to that produced by about 0.1-0.5 percent by weight of glutardialdehyde applied in an acid medium. It may further contain a cosmetically active agent such as an amino acid, peptide, protein, hormone, placenta-extract, phosphatide, tissue-extract, fresh cells and vitamins. The paste may be dried by heating, producing shrinkage of the foil to increase contact with the skin.
    Type: Grant
    Filed: April 9, 1976
    Date of Patent: December 26, 1978
    Assignee: Firma Carl Freudenberg
    Inventors: Klaus Braumer, Zdenek Eckmayer
  • Patent number: 4089333
    Abstract: Method of treating a wound or burn which comprises directly dressing its surface with non-woven fabric comprising staple fibers of spun, regenerated collagen substantially free of telopeptides is disclosed.
    Type: Grant
    Filed: June 22, 1976
    Date of Patent: May 16, 1978
    Assignee: Nippi, Incorporated
    Inventors: Akira Utsuo, Katsumi Matsutomo
  • Patent number: 4066083
    Abstract: A sterile surgical collagen product which has a felt or fleece-like structure and which exerts a haemostatic action, has a high absorption capacity for body fluids, promotes the regeneration of tissues, is highly resorptive, has substantially no antigenic activity and has optimum mechanical properties so as to make it suitable for being applied to or introduced into wounds or into bone cavities.
    Type: Grant
    Filed: June 3, 1976
    Date of Patent: January 3, 1978
    Assignee: Pentapharm A.G.
    Inventor: Peter E. Ries
  • Patent number: 4060081
    Abstract: A multilayer membrane, which is useful as synthetic skin, is disclosed herein. A first layer is formed from a material which does not provoke an immune response and which is also insoluble and nondegradable in the presence of body fluids and/or body enzymes. Preferred materials for the first layer are crosslinked composites of collagen and a mucopolysaccharide. A second layer is formed from a nontoxic material which controls the moisture flux of the overall membrane to about 0.1 to 1 mg./cm.sup.2 /hr. Suitable materials for the second layer include synthetic polymers such as silicone resins, polyacrylate or polymethacrylate esters or their copolymers, and polyurethanes.
    Type: Grant
    Filed: July 15, 1975
    Date of Patent: November 29, 1977
    Assignee: Massachusetts Institute of Technology
    Inventors: Ioannis V. Yannas, John F. Burke, Philip L. Gordon, Chor Huang
  • Patent number: 4034750
    Abstract: Skin-like collagen membranes are adapted for protecting a wound, lesion or the like on animal bodies. These collagen membranes are semipermeable and are electrochemically-linked to the damaged collagen fibrils of the animal body. This electrochemical biological junction is established iontophoretically from an electric potential derived from the body's own inherent electrical characteristics or a galvanic couple.
    Type: Grant
    Filed: April 22, 1975
    Date of Patent: July 12, 1977
    Inventor: Maurice Seiderman
  • Patent number: 4016877
    Abstract: Non-woven, liquid-laid, fibrous web having hemostatic and adhesive properties adapted to seal a wound formed of fibers consisting of an ionizable, water-insoluble, partial salt of collagen, the web when placed on a saline solution disintegrating completely and the fibers self disperse. The web is formed from a slurry of the fibers in a water-miscible organic liquid such as ethanol containing a small proportion of an ionizable acid.
    Type: Grant
    Filed: February 23, 1976
    Date of Patent: April 12, 1977
    Assignee: Avicon, Inc.
    Inventors: Mamerto M. Cruz, Jr., John H. Tenery, LaVerne C. Tressler
  • Patent number: 3955012
    Abstract: Medical articles composed of silicone rubber coated with collagen to be used in living body, are manufactured by subjecting a surface of shaped articles composed of silicone rubber to a spark discharge, coating the thus treated surface with an acidic aqueous solution of collagen and then drying said surface to form collagen layer and irradiating the shaped article coated with collagen with high energy ionizing radiation under an atmosphere having such a humidity that the water content of the coated collagen becomes more than 20% by weight.
    Type: Grant
    Filed: November 16, 1973
    Date of Patent: May 4, 1976
    Assignee: Zaidan Hojin, Seisan Kaihatsu Kagaku Kenkyusho
    Inventors: Seizo Okamura, Tsunetoshi Hino